REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the commencement of a proposed underwritten public offering in the United States, which may include shares sold in a ...

Nyxoah to Release First Quarter 2024 Financial Results on May 14, 2024 Mont-Saint-Guibert, Belgium – May 13, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter 2024 on Tuesday, May 14, 2024, after market close. Company management will host a conferen ...

REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the "Company") Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 12, 2024 The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders' meeting of the Company, to be held on Wednesday, June 12, 2024 at 2:00 p.m. CET at the Company's sea ...

Table of Contents As filed with the Securities and Exchange Commission on March 20, 2024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transiti ...

Nyxoah S.A. (NASDAQ:NYXH) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Mikaela Kirkwood - Corporate Communications & IR Manager Olivier Taelman - CEO Loïc Moreau - CFO Conference Call Participants Jon Block - Stifel Ed White - H.C. Wainwright Ross Osborn - Cantor Fitzgerald David Rescott - Baird Adam Maeder - Piper Sandler Laura Roba - Degroof Petercam Suraj Kalia - Oppenheimer Operator Good day and thank you for standing by. Welcome to Nyxoah Fourth Quarter 2023 Earnings C ...

In the Nordic countries, same thing goes for Finland. So there we did some implants already. And based on these data, we are trying to secure hospital reimbursement hospital by hospital, and also we generate more commercial implants in Finland. And what I was mentioning earlier on, I think a very important market will be the U.K. First step to enter the U.K. is to being allowed by NHS to participate in a tender. We have received this official communication that we are. Now the next steps will be how to comp ...

Company Participants Mikaela Kirkwood - Corporate Communications & Investor Relations Manager Olivier Taelman - Chief Executive Officer Loic Moreau - Chief Financial Officer Joe Federico - Stifel Ed White - H.C. Wainwright Adam Maeder - Piper Sandler Ross Osborn - Cantor Fitzgerald David Rescott - Baird Suraj Kalia - Oppenheimer & Company Good day, and thank you for standing by, and welcome to Nyxoah's Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Af ...

Nyxoah S.A. (NASDAQ:NYXH) Q1 2023 Earnings Conference Call May 16, 2023 4:30 PM ET Corporate Participants Conference Call Participants Jon Block - Stifel Adam Maeder - Piper Sandler Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer Operator Mikaela Kirkwood Participating from the company today will be Olivier Taelman, Chief Executive Officer; and Loic Moreau, Chief Financial Officer. During the call, we will discuss our operating activities and review our first quarter financial results released aft ...

Nyxoah S.A. (NASDAQ:NYXH) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Olivier Taelman - Chief Executive Officer Loïc Moreau - Chief Financial Officer Conference Call Participants Adam Maeder - PSC Jon Block - Stifel Suraj Kalia - Oppenheimer Operator Thank you for standing by. And welcome to the Nyxoah Fourth Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answe ...

Table of Contents As filed with the Securities and Exchange Commission on March 22, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transiti ...